59 related articles for article (PubMed ID: 16876150)
1. 1,3-Butadiene, styrene and lymphohaematopoietic cancers among North American synthetic rubber polymer workers: exposure-response analyses.
Sathiakumar N; Bolaji BE; Brill I; Chen L; Tipre M; Leader M; Arora T; Delzell E
Occup Environ Med; 2021 Dec; 78(12):859-868. PubMed ID: 34108254
[TBL] [Abstract][Full Text] [Related]
2. The effect of uncertainty in exposure estimation on the exposure-response relation between 1,3-butadiene and leukemia.
Graff JJ; Sathiakumar N; Macaluso M; Maldonado G; Matthews R; Delzell E
Int J Environ Res Public Health; 2009 Sep; 6(9):2436-55. PubMed ID: 19826555
[TBL] [Abstract][Full Text] [Related]
3. Industry-wide review of potential worker exposure to 1,3-butadiene during chemical manufacturing and processing as a reactant.
Panko J; Mittal L; Franke K; Maberti S; Zollers S; Millison K; Youssef N; Erraguntla N
J Occup Environ Hyg; 2024 Jan; 21(1):13-23. PubMed ID: 37788445
[TBL] [Abstract][Full Text] [Related]
4. Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment.
Checkoway H; Lees PSJ; Dell LD; Gentry PR; Mundt KA
Risk Anal; 2019 Jul; 39(7):1441-1464. PubMed ID: 30925210
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin adducts as an important marker of chronic exposure to low concentration of 1, 3-butadiene.
Ahmadkhaniha R; Izadpanah F; Rastkari N
J Environ Health Sci Eng; 2021 Dec; 19(2):1607-1611. PubMed ID: 34900292
[TBL] [Abstract][Full Text] [Related]
6. Application of biological monitoring for exposure assessment of 1.3 Butadiene.
Ahmadkhaniha R; Ghoochani M; Rastkari N
J Environ Health Sci Eng; 2020 Dec; 18(2):1265-1269. PubMed ID: 33312640
[TBL] [Abstract][Full Text] [Related]
7. Structures of exocyclic R,R- and S,S-N(6),N(6)-(2,3-dihydroxybutan-1,4-diyl)-2'-deoxyadenosine adducts induced by 1,2,3,4-diepoxybutane.
Kowal EA; Seneviratne U; Wickramaratne S; Doherty KE; Cao X; Tretyakova N; Stone MP
Chem Res Toxicol; 2014 May; 27(5):805-17. PubMed ID: 24741991
[TBL] [Abstract][Full Text] [Related]
8. Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction.
Soeteman-Hernández LG; Bos PM; Talhout R
Toxicol Sci; 2013 Dec; 136(2):566-80. PubMed ID: 24014643
[TBL] [Abstract][Full Text] [Related]
9. Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures.
Smith TJ; Bois FY; Lin YS; Brochot C; Micallef S; Kim D; Kelsey KT
J Breath Res; 2008 Sep; 2(3):037018. PubMed ID: 21386179
[TBL] [Abstract][Full Text] [Related]
10. Quantitative risk assessment of exposures to butadiene in EU occupational settings based on the University of Alabama at Birmingham epidemiological study.
Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2013 Mar; 65(2):214-25. PubMed ID: 23261476
[TBL] [Abstract][Full Text] [Related]
11. Critical assessment of epidemiological studies on the carcinogenicity of 1,3-butadiene and styrene.
Landrigan PJ
IARC Sci Publ; 1993; (127):375-88. PubMed ID: 8070884
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk assessment for 1,3-butadiene: dose-response modeling from an epidemiological perspective.
Sielken RL; Valdez-Flores C; Gargas ML; Kirman CR; Teta MJ; Delzell E
Chem Biol Interact; 2007 Mar; 166(1-3):140-9. PubMed ID: 16876150
[TBL] [Abstract][Full Text] [Related]
13. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships.
Cheng H; Sathiakumar N; Graff J; Matthews R; Delzell E
Chem Biol Interact; 2007 Mar; 166(1-3):15-24. PubMed ID: 17123495
[TBL] [Abstract][Full Text] [Related]
14. Butadiene cancer exposure-response modeling: based on workers in the styrene-butadiene-rubber industry: total leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia.
Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2011 Aug; 60(3):332-41. PubMed ID: 21600953
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review of occupational and general population cancer risk: 1,3-Butadiene exposure-response modeling for all leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, myeloid neoplasm and lymphoid neoplasm.
Sielken RL; Valdez-Flores C
Chem Biol Interact; 2015 Nov; 241():50-8. PubMed ID: 26070419
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
